RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM)

CUSIP: 76243J105

Q3 2018 13F Holders as of 30 Sep 2018

Holder snapshot 6 signals
Share change
+111,562
SEC-reported price per share
$29.17
Number of holders
77
Value change
+$2,062,008
Number of buys
46
Number of sells
37
Security identity 1 source field
Shares outstanding
69,012,275

Security key

76243J105

Report period

Q3 2018

Institutions

77

Top holders

10

Ownership snapshot

Top reported holders of RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
NEA Management Company, LLC
Disclosed value leader
NEA Management Company, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2018
13F Lead comparable stake: 7.1% Showing 1-6 of 15 holder rows.

Quick read

NEA Management Company, LLC leads the comparable SEC ownership view at 7.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5
NEA Management Company, LLC 7.1%
TRV GP, LLC 5.8%
MPM ASSET MANAGEMENT LLC 4.5%
BAKER BROS. ADVISORS LP 3.9%
JANUS HENDERSON GROUP PLC 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
NEA Management Company, LLC
13F
Company
13F
7.1%
$153,559,000
4,912,306 shares
30 Jun 2018
TRV GP, LLC
13F
Company
13F
5.8%
$124,460,000
3,981,437 shares
30 Jun 2018
MPM ASSET MANAGEMENT LLC
13F
Company
13F
4.5%
$96,121,000
3,074,893 shares
30 Jun 2018
BAKER BROS. ADVISORS LP
13F
Company
13F
3.9%
$84,658,000
2,708,200 shares
30 Jun 2018
JANUS HENDERSON GROUP PLC
13F
Company
13F
3.3%
$71,641,000
2,291,785 shares
30 Jun 2018
ORBIMED ADVISORS LLC
13F
Company
13F
3%
$64,552,000
2,065,000 shares
30 Jun 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
77
Shares
31,142,295
Rows available
77
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders
84
Q3 2018 holders
77
Holder diff
-7
Investor Q2 2018 Shares Q3 2018 Shares Share Diff Share Chg % Q2 2018 value Q3 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .